Skip to main content

Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations.

Publication ,  Conference
VanDeusen, JB; Osada, T; Morse, M; Clary, BM; Lyerly, HK; Nevins, JR; Clay, TM; Febbo, PG; Hsu, SD
Published in: Journal of Clinical Oncology
May 20, 2010

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

e14064 / e14064

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
VanDeusen, J. B., Osada, T., Morse, M., Clary, B. M., Lyerly, H. K., Nevins, J. R., … Hsu, S. D. (2010). Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations. In Journal of Clinical Oncology (Vol. 28, pp. e14064–e14064). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.e14064
VanDeusen, J. B., T. Osada, M. Morse, B. M. Clary, H. K. Lyerly, J. R. Nevins, T. M. Clay, P. G. Febbo, and S. D. Hsu. “Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations.” In Journal of Clinical Oncology, 28:e14064–e14064. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.e14064.
VanDeusen JB, Osada T, Morse M, Clary BM, Lyerly HK, Nevins JR, et al. Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. e14064–e14064.
VanDeusen, J. B., et al. “Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations.Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. e14064–e14064. Crossref, doi:10.1200/jco.2010.28.15_suppl.e14064.
VanDeusen JB, Osada T, Morse M, Clary BM, Lyerly HK, Nevins JR, Clay TM, Febbo PG, Hsu SD. Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. e14064–e14064.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

e14064 / e14064

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences